Foresee Edebi sanatlar yelken achim aigner leipzig university germany Tren istasyonu ilgisiz yerine getirmek
Achim AIGNER | University of Leipzig, Leipzig | Institute of Pharmacology, Pharmacy and Toxicology
Module III – CAS in Radiopharmaceutical Chemistry/Radiopharmacy | ETH Zurich
Mitarbeiter des Rudolf-Boehm-Institutes
Perspectives, issues and solutions in RNAi therapy: the expected and the less expected
Nanoparticle-mediated delivery of small RNA molecules in tumor therapy
Achim AIGNER | University of Leipzig, Leipzig | Institute of Pharmacology, Pharmacy and Toxicology
Functional Role and Therapeutic Potential of the Pim-1 Kinase in Colon Carcinoma
Mitarbeiter des Rudolf-Boehm-Institutes
Loop | Achim Aigner
SiRNA-transfection of SKOV-3-Luc cells with the Biontex K2® Transfection System Dipl.-Chem. Alexander Ewe, Prof. Achim Aigner U
Therapeutic Targeting of Stat3 Using Lipopolyplex Nanoparticle-Formulated siRNA in a Syngeneic Orthotopic Mouse Glioma Model
Achim AIGNER | University of Leipzig, Leipzig | Institute of Pharmacology, Pharmacy and Toxicology
Achim AIGNER | University of Leipzig, Leipzig | Institute of Pharmacology, Pharmacy and Toxicology
Targeted CRM197-PEG-PEI/siRNA Complexes for Therapeutic RNAi in Glioblastoma
Analysis of cellular and molecular antitumor effects upon inhibition of SATB1 in glioblastoma cells
Leipziger Pharmakologen forschen an Molekülen gegen Prostatakrebs
Multiple effects of the special ATâ•'rich binding protein 1 (SATB1) in colon carcinoma
Analysis of SATB1 in Head and Neck Squamous Cell Carcinoma
PDF) The proto-oncogene Pim-1 is a target of miR-33a | Marshall Thomas - Academia.edu
Biocompatibility and Efficacy of Oligomaltose-Grafted Poly(ethylene imine)s (OM-PEIs) for in Vivo Gene Delivery
